Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Legend Biotech (NASDAQ: LEGN), a global leader in cell therapy, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event will take place in New York, NY on September 4, 2024. CEO Ying Huang, Ph.D., will engage in a fireside chat at 2:35 p.m. ET.
Investors and interested parties can access the live webcast through the Investor Relations section of Legend's website. A replay of the webcast will be available approximately 48 hours after the event. This conference participation highlights Legend Biotech's commitment to engaging with the investment community and sharing insights into its cell therapy advancements.
Legend Biotech (NASDAQ: LEGN), un leader globale nella terapia cellulare, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley. L'evento si svolgerà a New York, NY il 4 settembre 2024. Il CEO Ying Huang, Ph.D., parteciperà a un incontro informale alle 14:35 ET.
Gli investitori e le parti interessate possono accedere al webcast in diretta tramite la sezione Relazioni con gli Investitori del sito web di Legend. Una registrazione del webcast sarà disponibile circa 48 ore dopo l'evento. Questa partecipazione alla conferenza sottolinea l'impegno di Legend Biotech nel coinvolgere la comunità degli investitori e nel condividere approfondimenti sui suoi progressi nella terapia cellulare.
Legend Biotech (NASDAQ: LEGN), un líder mundial en terapia celular, ha anunciado su participación en la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley. El evento tendrá lugar en Nueva York, NY el 4 de septiembre de 2024. El CEO Ying Huang, Ph.D., participará en una charla informal a las 2:35 p.m. ET.
Los inversores y partes interesadas pueden acceder al webcast en vivo a través de la sección de Relaciones con Inversores del sitio web de Legend. Una repetición del webcast estará disponible aproximadamente 48 horas después del evento. Esta participación en la conferencia resalta el compromiso de Legend Biotech de interactuar con la comunidad de inversores y compartir información sobre sus avances en terapia celular.
레전드 바이오텍 (NASDAQ: LEGN)는 세계적인 세포 치료의 선두주자로서 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 4일 뉴욕, NY에서 열립니다. CEO 잉 황, 박사가 오후 2시 35분 ET에 대담에 참여할 예정입니다.
투자자 및 관심 있는 당사자는 레전드 웹사이트의 투자자 관계 섹션을 통해 실시간 웨비나를 시청할 수 있습니다. 웨비나의 재생은 이벤트 후 약 48시간 후에 이용 가능합니다. 이번 컨퍼런스 참여는 레전드 바이오텍이 투자 커뮤니티와의 소통에 대한 의지와 세포 치료 분야의 발전에 대한 통찰력을 공유하고자 하는 commitment을 강조합니다.
Legend Biotech (NASDAQ: LEGN), un leader mondial dans le domaine de la thérapie cellulaire, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. L'événement se déroulera à New York, NY le 4 septembre 2024. Le PDG Ying Huang, Ph.D., participera à une discussion informelle à 14h35 ET.
Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct via la section Relations Investisseurs du site Web de Legend. Un replay du webinaire sera disponible environ 48 heures après l'événement. Cette participation à la conférence souligne l'engagement de Legend Biotech à interagir avec la communauté des investisseurs et à partager des informations sur ses avancées en matière de thérapie cellulaire.
Legend Biotech (NASDAQ: LEGN), ein weltweit führendes Unternehmen auf dem Gebiet der Zelltherapie, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley bekannt gegeben. Die Veranstaltung findet am 4. September 2024 in New York, NY statt. CEO Ying Huang, Ph.D., wird um 14:35 Uhr ET an einem informellen Gespräch teilnehmen.
Investoren und Interessierte können über den Bereich Investor Relations auf der Website von Legend auf das Live-Webcast zugreifen. Eine Wiederholung des Webcasts wird etwa 48 Stunden nach der Veranstaltung verfügbar sein. Die Teilnahme an dieser Konferenz unterstreicht das Engagement von Legend Biotech, mit der Investitionsgemeinschaft in Kontakt zu treten und Einblicke in die Fortschritte in der Zelltherapie zu teilen.
- None.
- None.
SOMERSET, N.J., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Wednesday, September 4, 2024, at 2:35 p.m. ET.
The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.
ABOUT LEGEND BIOTECH
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.
Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.
INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT:
Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com
FAQ
When and where is Legend Biotech (LEGN) participating in the Morgan Stanley Healthcare Conference?
Who will represent Legend Biotech (LEGN) at the Morgan Stanley Healthcare Conference?
What time is Legend Biotech's (LEGN) fireside chat at the Morgan Stanley conference?
How can investors access Legend Biotech's (LEGN) presentation at the Morgan Stanley conference?
When will the replay of Legend Biotech's (LEGN) Morgan Stanley conference webcast be available?
